Microarray data on gene modulation by HIV‐1 in immune cells: 2000–2006

Here, we review 34 HIV microarray studies in human immune cells over the period of 2000–March 2006 with emphasis on analytical approaches used and conceptual advances on HIV modulation of target cells (CD4 T cell, macrophage) and nontargets such as NK cell, B cell, and dendritic cell subsets. Results to date address advances on gene modulation associated with immune dysregulation, susceptibility to apoptosis, virus replication, and viral persistence following in vitro or in vivo infection/exposure to HIV‐1 virus or HIV‐1 accessory proteins. In addition to gene modulation associated with known functional correlates of HIV infection and replication (e.g., T cell apoptosis), microarray data have yielded novel, potential mechanisms of HIV‐mediated pathogenesis such as modulation of cholesterol biosynthetic genes in CD4 T cells (relevant to virus replication and infectivity) and modulation of proteasomes and histone deacetylases in chronically infected cell lines (relevant to virus latency). Intrinsic challenges in summarizing gene modulation studies remain in development of sound approaches for comparing data obtained using different platforms and analytical tools, deriving unifying concepts to distil the large volumes of data collected, and the necessity to impose a focus for validation on a small fraction of genes. Notwithstanding these challenges, the field overall continues to demonstrate progress in expanding the pool of target genes validated to date in in vitro and in vivo datasets and understanding the functional correlates of gene modulation to HIV‐1 pathogenesis in vivo.

[1]  Malik Yousef,et al.  Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. , 2006, Blood.

[2]  M. Federico,et al.  HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis. , 2006, Experimental cell research.

[3]  R. Lempicki,et al.  R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Martin L. Smith,et al.  Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. , 2006, Anticancer research.

[5]  David B. Allison,et al.  The PowerAtlas: a power and sample size atlas for microarray experimental design and research , 2006, BMC Bioinformatics.

[6]  A. Marcello Latency: the hidden HIV-1 challenge , 2006, Retrovirology.

[7]  R. Lempicki,et al.  Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 , 2006, The Journal of Immunology.

[8]  F. Marincola,et al.  Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation , 2005, Journal of Translational Medicine.

[9]  S. Munier,et al.  Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency , 2005, Retrovirology.

[10]  Denis Puthier,et al.  Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV , 2005, AIDS.

[11]  Yonghua Zhu,et al.  HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells. , 2005, Virus research.

[12]  Thomas Werner,et al.  Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. , 2005, Gene.

[13]  D. Pietraforte,et al.  HIV-1 Nef regulates the release of superoxide anions from human macrophages. , 2005, The Biochemical journal.

[14]  J. Mullins,et al.  Nef Induces Multiple Genes Involved in Cholesterol Synthesis and Uptake in Human Immunodeficiency Virus Type 1-Infected T Cells , 2005, Journal of Virology.

[15]  Michael D. George,et al.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Pomerantz,et al.  Molecular Interactions of Human Immunodeficiency Virus Type 1 with Primary Human Oral Keratinocytes , 2005, Journal of Virology.

[17]  W. Greene,et al.  Host factors regulating post-integration latency of HIV. , 2005, Trends in microbiology.

[18]  E. Zimmerman,et al.  ATR and GADD45α mediate HIV-1 Vpr-induced apoptosis , 2005, Cell Death and Differentiation.

[19]  M. Sporn,et al.  Human Immunodeficiency Virus Type 1-Induced Macrophage Gene Expression Includes the p21 Gene, a Target for Viral Regulation , 2005, Journal of Virology.

[20]  M. Giacca Retrovirology BioMed Central Commentary HIV-1 Tat, apoptosis and the mitochondria: a tubulin link? , 2005 .

[21]  D. Weiner,et al.  HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. , 2004, International immunology.

[22]  Shin-ichi Hashimoto,et al.  Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals. , 2004, International immunopharmacology.

[23]  S. Zeichner,et al.  Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication , 2004, Retrovirology.

[24]  T. Smithgall,et al.  HIV-1 Nef Promotes Survival of TF-1 Macrophages by Inducing Bcl-XL Expression in an Extracellular Signal-regulated Kinase-dependent Manner* , 2004, Journal of Biological Chemistry.

[25]  L. Pulliam,et al.  Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load , 2004, Journal of Neuroimmunology.

[26]  David J. Volsky,et al.  Microarray analysis of changes in cellular gene expression induced by productive infection of primary human astrocytes: implications for HAD , 2004, Journal of Neuroimmunology.

[27]  F. González-Scarano,et al.  Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression , 2004, Journal of Neuroimmunology.

[28]  Jacques Corbeil,et al.  Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. , 2004, AIDS research and human retroviruses.

[29]  R. Siliciano,et al.  The multifactorial nature of HIV-1 latency. , 2004, Trends in molecular medicine.

[30]  H. Baker,et al.  Impact on Genetic Networks in Human Macrophages by a CCR5 Strain of Human Immunodeficiency Virus Type 1 , 2004, Journal of Virology.

[31]  O. Pickeral,et al.  Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily , 2004, The Journal of experimental medicine.

[32]  K. Becker,et al.  Antigen-Specific Gene Expression Profiles of Peripheral Blood Mononuclear Cells Do Not Reflect Those of T-Lymphocyte Subsets , 2004, Clinical Diagnostic Laboratory Immunology.

[33]  S. Zeichner,et al.  Host Cell Gene Expression during Human Immunodeficiency Virus Type 1 Latency and Reactivation and Effects of Targeting Genes That Are Differentially Expressed in Viral Latency , 2004, Journal of Virology.

[34]  V. Robert-Hebmann,et al.  Apoptosis of uninfected cells induced by HIV envelope glycoproteins , 2004, Retrovirology.

[35]  M. Simm,et al.  Microarray analysis of differentially expressed genes in cells resistant to HIV-1. , 2004, Immunology letters.

[36]  Mauro Piacentini,et al.  NF-κB and p53 Are the Dominant Apoptosis-inducing Transcription Factors Elicited by the HIV-1 Envelope , 2004, The Journal of experimental medicine.

[37]  B. Majumder,et al.  Differential regulation of host cellular genes by HIV-1 viral protein R (Vpr): cDNA microarray analysis using isogenic virus. , 2004, Biochemical and biophysical research communications.

[38]  C. Whiteford,et al.  Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage , 2004, Oncogene.

[39]  J. Orenstein,et al.  Viral and host cofactors facilitate HIV‐1 replication in macrophages , 2003, Journal of leukocyte biology.

[40]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[41]  M. Rizzo,et al.  Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells. , 2003, Molecular cancer therapeutics.

[42]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[43]  J. Alimonti,et al.  Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. , 2003, The Journal of general virology.

[44]  B. Peterlin,et al.  Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Louise C. Showe,et al.  Classification and Prediction of Survival in Patients with the Leukemic Phase of Cutaneous T Cell Lymphoma , 2003, The Journal of experimental medicine.

[46]  M. Gougeon,et al.  Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.

[47]  J. Jäger,et al.  HIV-1 Nef Induces the Release of Inflammatory Factors from Human Monocyte/Macrophages: Involvement of Nef Endocytotic Signals and NF-κB Activation 1 , 2003, The Journal of Immunology.

[48]  K. Kinzler,et al.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christopher J. Miller,et al.  HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages , 2003, Nature Medicine.

[50]  I. Chen,et al.  Depletion of Wee-1 Kinase Is Necessary for both Human Immunodeficiency Virus Type 1 Vpr- and Gamma Irradiation-Induced Apoptosis , 2003, Journal of Virology.

[51]  K. Kedzierska,et al.  Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[52]  R. Lempicki,et al.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Jerome H. Kim,et al.  HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. , 2003, Virology.

[54]  Roger E Bumgarner,et al.  Cellular Gene Expression upon Human Immunodeficiency Virus Type 1 Infection of CD4+-T-Cell Lines , 2003, Journal of Virology.

[55]  F. Krebs,et al.  Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. , 2002, Journal of neurovirology.

[56]  B. Hoffman,et al.  GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress , 2002, Journal of cellular physiology.

[57]  Donald E Ingber,et al.  Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope , 2002, The EMBO journal.

[58]  A. Henderson,et al.  CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells. , 2002, Virology.

[59]  Richard A Lempicki,et al.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  F. Kashanchi,et al.  Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals , 2002, BMC Biochemistry.

[61]  Geoffrey J McLachlan,et al.  Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  I. Hewlett,et al.  Bcl-2 Upregulation by HIV-1 Tat during Infection of Primary Human Macrophages in Culture , 2002, Journal of Biomedical Science.

[63]  Katherine Kedzierska,et al.  HIV-1 Down-Modulates γ Signaling Chain of FcγR in Human Macrophages: A Possible Mechanism for Inhibition of Phagocytosis1 , 2002, The Journal of Immunology.

[64]  Nelson L Michael,et al.  Impact of viral infection on the gene expression profiles of proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF. , 2002, AIDS research and human retroviruses.

[65]  C. Muratori,et al.  HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. , 2001, Blood.

[66]  D. Weiner,et al.  HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro. , 2001, Virology.

[67]  L Leoni,et al.  Temporal gene regulation during HIV-1 infection of human CD4+ T cells. , 2001, Genome research.

[68]  A. McMichael,et al.  Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. , 2001, Immunity.

[69]  B. Peterlin,et al.  Nef increases infectivity of HIV via lipid rafts , 2001, Current Biology.

[70]  D. Olive,et al.  The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif Protein* , 2001, The Journal of Biological Chemistry.

[71]  T. Smithgall,et al.  HIV-1 Nef Promotes Survival of Myeloid Cells by a Stat3-dependent Pathway , 2001, The Journal of Biological Chemistry.

[72]  W. Greene,et al.  HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.

[73]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[74]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[75]  Shuxian Hu,et al.  Activation of human microglial cells by HIV-1 gp41 and Tat proteins. , 2000, Clinical immunology.

[76]  D. Weiner,et al.  HIV‐1 Vpr regulates expression of β chemokines in human primary lymphocytes and macrophages , 2000, Journal of leukocyte biology.

[77]  P. Branton,et al.  Human immunodeficiency virus type 1 Vpr‐mediated G2 cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A , 2000 .

[78]  H. Akari,et al.  Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr. , 2000, Microbes and infection.

[79]  L. Montaner,et al.  IL‐13 and TNF‐α  inhibit dual‐tropic HIV‐1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post‐entry viral gene expression , 2000 .

[80]  Roger E Bumgarner,et al.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. , 2000, Virology.

[81]  V. Sasseville,et al.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.

[82]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[83]  M. Giacca,et al.  Human Immunodeficiency Virus Type 1 Tat Protein Activates Transcription Factor NFk B through the Cellular Interferon-Inducible , Double-Stranded RNA-Dependent Protein Kinase , PKR , 1999 .

[84]  K. Saksela,et al.  Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events. , 1999, Journal of molecular biology.

[85]  X. Wang,et al.  Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45 , 1999, Oncogene.

[86]  G. Chrousos,et al.  The HIV-1 Virion-associated Protein Vpr Is a Coactivator of the Human Glucocorticoid Receptor , 1999, Psychoneuroendocrinology.

[87]  M. K. Meintzer,et al.  Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[88]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[89]  D. Green,et al.  HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor κB , 1997, Nature Medicine.

[90]  D. Weiner,et al.  HIV‐1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro , 1997, Journal of leukocyte biology.

[91]  R. Tibshirani,et al.  Penalized Discriminant Analysis , 1995 .

[92]  J. D. Engel,et al.  Human T cell transcription factor GATA-3 stimulates HIV-1 expression. , 1993, Nucleic acids research.

[93]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[94]  J. Mcdougal,et al.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. , 1985, Journal of immunology.

[95]  M. Keuls,et al.  The use of the „studentized range” in connection with an analysis of variance , 1952, Euphytica.

[96]  D. Newman,et al.  THE DISTRIBUTION OF RANGE IN SAMPLES FROM A NORMAL POPULATION, EXPRESSED IN TERMS OF AN INDEPENDENT ESTIMATE OF STANDARD DEVIATION , 1939 .

[97]  M. Theodoropoulou,et al.  Mining microarray data to identify transcription factors expressed in naïve resting but not activated T lymphocytes , 2004, Genes and Immunity.

[98]  Sayan Mukherjee,et al.  Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..

[99]  J. Jäger,et al.  HIV-1 Nef Induces the Release of Inflammatory Factors from Human Monocyte/Macrophages: Involvement of Nef Endocytotic Signals and NF- B Activation , 2003 .

[100]  Michael Bittner,et al.  Effects of HIV-1 Nef on cellular gene expression profiles. , 2002, Journal of biomedical science.

[101]  P. Branton,et al.  Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A. , 2000, The EMBO journal.

[102]  S. Croul,et al.  Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. , 1999, Journal of neurovirology.

[103]  Vladimir Vapnik,et al.  Statistical learning theory , 1998 .

[104]  C. Payá,et al.  Apoptosis in AIDS. , 1997, Advances in pharmacology.

[105]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[106]  R. F. Snedaker On AIDS. , 1987, The New York state dental journal.

[107]  C. Bonferroni Il calcolo delle assicurazioni su gruppi di teste , 1935 .